Summary

Serotonin imaging has emerged as a pivotal tool for unraveling the neurochemical substrates of mood disorders, encompassing major depressive disorder, seasonal affective disorder and social anxiety. By visualising key components of the serotonergic system in vivo, researchers have elucidated alterations in transporter availability, receptor density and enzymatic activity that underlie affective dysregulation. Positron emission tomography (PET) and single-photon emission computed tomography (SPECT) studies consistently demonstrate regional reductions in serotonin transporter binding within the midbrain and limbic structures, suggesting impaired reuptake mechanisms. Parallel investigations of monoamine oxidase A reveal elevated enzyme levels in depressed individuals, indicative of increased serotonin catabolism. Advances in radiotracer design have enabled more precise quantification of presynaptic and postsynaptic targets, while genetic imaging studies have begun to link serotonin-related polymorphisms with in vivo measures of neurotransmitter turnover. Collectively, these findings support a multifaceted model in which diminished transporter function, heightened catabolic activity and receptor dysregulation converge to disrupt synaptic serotonin dynamics, ultimately contributing to the pathophysiology of mood disturbances. Ongoing work seeks to integrate longitudinal imaging with clinical outcomes, thereby refining personalised treatment strategies and identifying biomarkers for therapeutic response.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Serotonin Imaging in Mood Disorders publication trend

The graph below shows the total number of articles in serotonin imaging in mood disorders across all publications each year (not limited to Nature Index journals).

Technical terms

Positron emission tomography (PET): A neuroimaging technique that uses radiolabelled tracers to visualise and quantify molecular targets in the living brain.

Serotonin transporter (SERT): A presynaptic membrane protein responsible for reuptake of serotonin from the synaptic cleft, regulating extracellular neurotransmitter levels.

Monoamine oxidase A (MAO-A): An enzyme that degrades monoamine neurotransmitters, including serotonin, thereby modulating synaptic concentrations.

Dopamine transporter (DAT): A presynaptic protein that mediates the reuptake of dopamine, often imaged alongside serotonin targets to assess monoaminergic balance.

References

  1. Impact of genetic variants within serotonin turnover enzymes on human cerebral monoamine oxidase A in vivo. Translational Psychiatry (2023).
  2. Meta-Analysis of Molecular Imaging of Serotonin Transporters in Major Depression. Cerebrovascular and Brain Metabolism Reviews (2014).
  3. Expectancy effects on serotonin and dopamine transporters during SSRI treatment of social anxiety disorder: a randomized clinical trial. Translational Psychiatry (2021).
  4. Brain monoamine oxidase A in seasonal affective disorder and treatment with bright light therapy. Translational Psychiatry (2018).

About these summaries

This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.

Nature Strategy Reports
Turn complex research questions into confident strategic decisions 

When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.

  • Benchmark your performance against global peers using robust, methodologically sound analysis.

  • Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.

  • Gain tailored, decision-ready recommendations aligned to your strategic priorities.

Talk to us to learn more about our data dashboards and bespoke strategy reports.

Nature Masterclasses
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.

Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:

  • Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.

  • Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.

  • Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.

Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.